Free Trial

iRhythm Technologies (IRTC) Competitors

iRhythm Technologies logo
$148.53 +1.05 (+0.71%)
Closing price 04:00 PM Eastern
Extended Trading
$144.49 -4.04 (-2.72%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRTC vs. SNN, SOLV, PEN, STVN, GKOS, NARI, TMDX, BLCO, INSP, and SLNO

Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Smith & Nephew (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

iRhythm Technologies vs.

Smith & Nephew (NYSE:SNN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

Smith & Nephew received 35 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.24% of users gave iRhythm Technologies an outperform vote while only 54.10% of users gave Smith & Nephew an outperform vote.

CompanyUnderperformOutperform
Smith & NephewOutperform Votes
449
54.10%
Underperform Votes
381
45.90%
iRhythm TechnologiesOutperform Votes
414
66.24%
Underperform Votes
211
33.76%

Smith & Nephew currently has a consensus price target of $28.00, suggesting a potential downside of 6.90%. iRhythm Technologies has a consensus price target of $133.73, suggesting a potential downside of 9.97%. Given Smith & Nephew's higher possible upside, analysts clearly believe Smith & Nephew is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
iRhythm Technologies
0 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.91

Smith & Nephew has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Smith & Nephew's return on equity of 0.00% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & NephewN/A N/A N/A
iRhythm Technologies -19.14%-118.83%-11.34%

Smith & Nephew has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.

In the previous week, Smith & Nephew had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 7 mentions for Smith & Nephew and 5 mentions for iRhythm Technologies. Smith & Nephew's average media sentiment score of 0.75 beat iRhythm Technologies' score of 0.55 indicating that Smith & Nephew is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smith & Nephew
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
iRhythm Technologies
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

25.6% of Smith & Nephew shares are held by institutional investors. 1.0% of Smith & Nephew shares are held by insiders. Comparatively, 1.1% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Smith & Nephew has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew$5.81B2.27$263M$2.1613.92
iRhythm Technologies$618.59M7.67-$123.41M-$3.14-47.30

Summary

Smith & Nephew beats iRhythm Technologies on 12 of the 18 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRTC vs. The Competition

MetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4.74B$4.39B$5.57B$8.67B
Dividend YieldN/A42.68%5.27%4.19%
P/E Ratio-40.8028.2027.2020.16
Price / Sales7.6770.64412.92162.04
Price / CashN/A51.0838.2534.64
Price / Book21.685.967.114.72
Net Income-$123.41M$67.01M$3.23B$247.80M
7 Day Performance2.45%2.64%4.61%3.36%
1 Month Performance7.86%18.46%13.35%9.71%
1 Year Performance56.13%18.42%31.75%14.41%

iRhythm Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRTC
iRhythm Technologies
1.1176 of 5 stars
$148.53
+0.7%
$133.73
-10.0%
+54.2%$4.74B$618.59M-40.801,790
SNN
Smith & Nephew
2.3589 of 5 stars
$29.17
+0.7%
$28.00
-4.0%
+13.4%$12.78B$5.81B13.5120,100
SOLV
Solventum
0.3277 of 5 stars
$73.08
0.0%
$80.29
+9.9%
+32.8%$12.64B$8.31B33.8322,000
PEN
Penumbra
4.5711 of 5 stars
$256.57
-3.9%
$302.40
+17.9%
+35.8%$9.94B$1.24B754.623,900
STVN
Stevanato Group
1.7863 of 5 stars
€22.01
-0.9%
N/A+25.0%$6.67B$1.12B46.834,650Positive News
GKOS
Glaukos
4.645 of 5 stars
$94.89
+0.6%
$134.67
+41.9%
-17.0%$5.42B$404.52M-33.06780
NARI
Inari Medical
N/A$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
TMDX
TransMedics Group
1.5134 of 5 stars
$123.94
-2.5%
$126.70
+2.2%
+1.6%$4.19B$488.23M131.85210
BLCO
Bausch + Lomb
3.6742 of 5 stars
$11.46
-0.1%
$15.50
+35.3%
-21.9%$4.05B$4.83B-12.5912,500Analyst Forecast
INSP
Inspire Medical Systems
4.7924 of 5 stars
$133.66
-3.3%
$211.91
+58.5%
-13.5%$3.94B$840.11M77.26760
SLNO
Soleno Therapeutics
4.8593 of 5 stars
$75.66
+3.1%
$106.78
+41.1%
+70.6%$3.81BN/A-22.7930Positive News
Analyst Revision

Related Companies and Tools


This page (NASDAQ:IRTC) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners